Serum antinuclear antibodies associate with severe disease activity in neuromyelitis optica spectrum disorder

被引：0
|
作者：
Wang, Rui [1 ]
Sun, Dongren [1 ]
Zhou, Hongyu [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Neurol, Chengdu, Peoples R China
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1035/437
引用
收藏
页码：672 / 672
页数：1
相关论文
共 50 条
  • [31] Update on neuromyelitis optica spectrum disorder
    Holroyd, Kathryn B.
    Manzano, Giovanna S.
    Levy, Michael
    CURRENT OPINION IN OPHTHALMOLOGY, 2020, 31 (06) : 462 - 468
  • [32] The serum levels of interleukin 17 in patients with neuromyelitis optica spectrum disorder
    Varzandi, T.
    Omidifar, A.
    Torkamani, M.
    Rezaeimanesh, N.
    Kazemi, R.
    Sahraian, M. A.
    Moghadasi, A. N.
    Maghbooli, Z.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 201 - 201
  • [33] Intractable cough as characteristic symptom of neuromyelitis optica and neuromyelitis optica spectrum disorder
    Fujita-Nakata, M.
    Tomioka, R.
    Tanaka, K.
    Nakanishi, M.
    Nagayama, S.
    Takahashi, R.
    Machiya, T.
    Hamada, T.
    Matsui, M.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (04) : 576 - 577
  • [34] Patients with Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder: Turkish Multicenter Data
    Altintas, A.
    Karabudak, R.
    Balci, B. Petek
    Terzi, M.
    Soysal, A.
    Saip, S.
    Kurne, A. Tuncer
    Uygunoglu, U.
    Nalbantoglu, M.
    Gozubatik-Celik, G.
    Isik, N.
    Celik, Y.
    Gokcay, F.
    Duman, T.
    Boz, C.
    Yucesan, C.
    Celebisoy, N.
    Diker, S.
    Isikay, I. C.
    Kansu, T.
    Siva, A.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (06) : 824 - 825
  • [35] Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset
    Collongues, N.
    Marignier, R.
    Jacob, A.
    Leite, M. I.
    Sivas, A.
    Paul, F.
    Zephir, H.
    Akman-Demirs, G.
    Elsone, L.
    Jarius, S.
    Papeix, C.
    Mutch, K.
    Saips, S.
    Wildemann, B.
    Kitley, J.
    Karabudak, R.
    Aktas, O.
    Kuscu, D.
    Altintas, A.
    Palace, J.
    Confavreux, C.
    De Seze, J.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (08) : 1086 - 1094
  • [36] Antiphospholipid antibodies: a possible biomarker of disease activity in multiple sclerosis and neuromyelitis optica spectrum disorders
    Tatiana Koudriavtseva
    Domenico Plantone
    Rosaria Renna
    Journal of Neurology, 2014, 261 : 2028 - 2029
  • [37] Antiphospholipid antibodies: a possible biomarker of disease activity in multiple sclerosis and neuromyelitis optica spectrum disorders
    Koudriavtseva, Tatiana
    Plantone, Domenico
    Renna, Rosaria
    JOURNAL OF NEUROLOGY, 2014, 261 (10) : 2028 - 2029
  • [38] New progress in the treatment of neuromyelitis optica spectrum disorder with monoclonal antibodies (Review)
    Xie, Qinfang
    Sun, Mengjiao
    Sun, Jing
    Zheng, Ting
    Wang, Manxia
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (02)
  • [39] Pathogenic antibodies to AQP4: Neuromyelitis optica spectrum disorder (NMOSD)
    Wright, Sukhvir K.
    Wassmer, Evangeline
    Vincent, Angela
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2021, 1863 (12):
  • [40] Evidence for and Against Subclinical Disease Activity and Progressive Disease in MOG Antibody Disease and Neuromyelitis Optica Spectrum Disorder
    Molazadeh, Negar
    Filippatou, Angeliki G.
    Vasileiou, Eleni S.
    Levy, Michael
    Sotirchos, Elias S.
    NEUROLOGY, 2022, 99 (23) : S74 - S74
12345